Combined Hypomethylating Agents (HMA) and Histone Deacetylase Inhibitors (HDACi) Exhibit Compelling Activity in Patients with Peripheral T-Cell Lymphoma (PTCL) with High Complete Response Rates in Angioimmunoblastic T-Cell Lymphoma (AITL)

被引：3
|
作者：
Falchi, Lorenzo [1 ]
Lue, Jennifer Kimberly [2 ]
Montanari, Francesca [3 ]
Marchi, Enrica [3 ]
Amengual, Jennifer E. [2 ]
Sawas, Ahmed [3 ]
Deng, Changchun [2 ]
Khan, Karen [1 ]
Kim, Hyea [1 ]
Atkins, Laine E. [1 ]
Rada, Aishling M. [1 ]
Serge, Cremers [4 ]
O'Connor, Owen A. [5 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Columbia Univ, Med Ctr, Dept Med, Ctr Lymphoid Malignancies, New York, NY USA
[3] Columbia Univ, Med Ctr, Ctr Lymphoid Malignancies, New York, NY USA
[4] Columbia Univ, Med Ctr, Irving Inst Clin & Translat Res, New York, NY USA
[5] Columbia Univ, Dept Med, Ctr Lymphoid Malignancies, New York, NY USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1002
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
    Lu, Guang
    Jin, Shikai
    Lin, Suwen
    Gong, Yuping
    Zhang, Liwen
    Yang, Jingwen
    Mou, Weiwei
    Du, Jun
    CLINICAL EPIGENETICS, 2023, 15 (01)
  • [2] Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
    Guang Lu
    Shikai Jin
    Suwen Lin
    Yuping Gong
    Liwen Zhang
    Jingwen Yang
    Weiwei Mou
    Jun Du
    Clinical Epigenetics, 15
  • [3] Validation of Angioimmunoblastic T-Cell Lymphoma (AITL) Score in Korean AITL Patients
    Moon, Bohyun
    Cho, Hyungwoo
    Yoo, Changhoon
    Kim, Hyung-Don
    Kim, Shin
    Ryu, Jin Sook
    Huh, Jooryung
    Park, Chan-Sik
    Lee, Sang-wook
    Lee, Yoon Sei
    Suh, Cheolwon
    BLOOD, 2022, 140 : 12011 - 12012
  • [4] The Combination of Hypomethylating Agents and Histone Deacetylase Inhibitors (HDACi) Are Synergistically Cytotoxic and Reverse the Malignant Phenotype in Preclinical Models of T-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 9 - 11
  • [5] Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL)
    Ma, Helen
    O'Connor, Owen A.
    Marchi, Enrica
    SEMINARS IN HEMATOLOGY, 2021, 58 (02) : 95 - 102
  • [6] Histone Deacetylase Inhibitors for Cutaneous T-Cell Lymphoma
    Duvic, Madeleine
    DERMATOLOGIC CLINICS, 2015, 33 (04) : 757 - +
  • [7] The Combination of Histone Deacetylase Inhibitors and Hypomethylating Agents Exhibits Marked Synergy In Preclinical Models of T-Cell Lymphoma
    Marchi, Enrica
    Bongero, Danielle C.
    Kalac, Matko
    Scotto, Luigi
    O'Connor, Owen A.
    BLOOD, 2010, 116 (21) : 1605 - 1606
  • [8] The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma
    Marchi, Enrica
    Zullo, Kelly M.
    Amengual, Jennifer E.
    Kalac, Matko
    Bongero, Danielle
    McIntosh, Christine M.
    Fogli, Laura K.
    Rossi, Maura
    Zinzani, Pier L.
    Pileri, Stefano A.
    Piccaluga, Pier P.
    Fuligni, Fabio
    Scotto, Luigi
    O'Connor, Owen A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (02) : 215 - 226
  • [9] Comprehensive Genomic Profiling of Angioimmunoblastic T-Cell Lymphoma (AITL) in Chinese Patients
    Zhong, Lihua
    Wang, Jianchao
    Chen, Yanping
    Lin, Weiqing
    Liu, Xiaoyan
    Dou, Ying
    Sun, Lihua
    Zhao, Songhui
    Dong, Xiaowei
    Dave, Utpal
    Wang, Kai
    Chen, Gang
    BLOOD, 2018, 132
  • [10] Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma
    Yamasaki, Satoshi
    Yoshida, Shuro
    Kato, Koji
    Choi, Ilseung
    Imamura, Yutaka
    Kohno, Kentaro
    Henzan, Hideho
    Tanimoto, Kazuki
    Ogawa, Ryosuke
    Suehiro, Youko
    Miyamoto, Toshihiro
    Eto, Tetsuya
    Ohshima, Koichi
    Akashi, Koichi
    Iwasaki, Hiromi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 74 - 83
12345